オプション
家 AIプロンプト一覧 哲学/宗教 倫理的意思決定支援

倫理的意思決定支援

{:__('collect %s',倫理的意思決定支援)}

功利主義と義務論の枠組みを用いてビジネス上の道徳的ジレンマを分析し、コンプライアンスと人間味のある意思決定の助言を提供します。

プロンプト内容 コピー コピー

Act as a senior corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please evaluate whether the company should proactively recall the drug and disclose risks by combining utilitarian considerations of overall well-being with deontological respect for patient informed consent, while also considering the impact on shareholder interests, employee livelihoods, and public health. Finally, output an ethical decision report containing risk assessment, stakeholder analysis, and recommended action plans, ensuring the advice complies with legal baselines and embodies corporate social responsibility.

コピー コピー

シニア企業倫理コンサルタントとして、以下の具体的なビジネスシナリオに対する深い道徳的分析を行ってください。製薬会社が、長期服用後に軽度だが不可逆的な神経副作用を持つベストセラー医薬品を発見したが、中止すると多くの慢性疾患患者の病状が悪化することを発見した場合を考えます。全体的な幸福に関する功利主義の考慮と、患者のインフォームド・コンセントに対する義務論的尊重を組み合わせ、株主の利益、従業員の生計、公衆衛生への影響を考慮しつつ、会社が医薬品の自主回収とリスク開示を行うべきかを評価してください。最後に、リスク評価、ステークホルダー分析、推奨される行動計画を含む倫理的意思決定レポートを出力し、その助言が法的基準に準拠し、企業の社会的責任を体現していることを確保してください。

コピー コピー
コメント (0)
0/300

おすすめ

倫理的意思決定支援
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its long-marketed common drug has mild but irreversible neurological side effects with long-term use, yet stopping the medication carries higher risks and no alternative therapy exists. The company faces a choice between proactively recalling and disclosing the information, which could lead to massive financial losses or even bankruptcy, or hiding the information, which violates patient safety principles. Please evaluate the moral weight of this situation from both utilitarian (maximizing overall well-being) and deontological (respecting patient informed consent and autonomy) perspectives, and provide a phased action recommendation that balances shareholder interests with patient safety, focusing on how to establish a trust mechanism in an environment of information asymmetry.
倫理的意思決定支援
Please act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma between launching early to seize market share while accepting potential side effect risks. Please analyze the long-term impact of this decision on various stakeholders (patients, shareholders, employees, public) by combining the principle of greatest happiness from utilitarianism with the requirement for procedural justice from deontology. Output a comprehensive recommendation report including risk assessment, ethical justification, and alternative solutions, ensuring logical rigor and compliance with business ethics standards.
倫理的意思決定支援
Act as a corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes severe side effects in a very small number of long-term users, but a recall would bankrupt the company and affect thousands of patients relying on it. Please evaluate the moral weight of three paths—recall, concealment, or limited disclosure—by combining utilitarian consequence analysis with deontological respect for human dignity, and provide a specific action framework that balances social responsibility and corporate survival, avoiding rigid instructional language and narrating the reasoning process naturally.
倫理的意思決定支援
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its established basic drug has potential serious side effects for a very small number of individuals with specific genetic profiles after long-term use, but the cost of recall would lead to company bankruptcy and affect medication accessibility for millions of ordinary patients. Please evaluate the ethical weights of both recall and non-recall options by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological perspective of moral responsibility for harm to individuals, and provide a balanced recommendation that balances business sustainability with moral legitimacy, focusing on how to distribute risks and responsibilities among stakeholders.
倫理的意思決定支援
Act as a senior corporate ethics consultant to evaluate the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but insufficiently disclosed side effects with long-term use. Continuing sales maintains stock price and employment but violates patient知情权 (right to know). Please analyze the moral conflict in this context by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting individual autonomy. Provide a comprehensive recommendation that balances legal compliance, corporate social responsibility, and long-term reputation management, ensuring the logic is rigorous and actionable.
倫理的意思決定支援
Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes mild but reversible liver damage in long-term users, affecting only 0.5% of patients, with no alternative treatments available. The company must decide whether to immediately recall and suspend sales, which would cause stock price drops and shareholder lawsuits, but might save some patients' health. Please evaluate the moral weight of both recall and non-recall options using both utilitarian (maximizing overall well-being) and deontological (respecting patient autonomy and non-maleficence) ethical frameworks, and provide a final action recommendation that balances legal compliance, corporate social responsibility, and patient interests, ensuring rigorous logic and adherence to business ethics standards.
OR